OXA (17-33)

Orexin A (17-33), truncated form of orexin A, acts as potent and selective peptide orexin OX1 receptor antagonist.

Online Inquiry

CAT#R1057
CAS343268-91-7
M.F/FormulaC79H125N23O22
M.W/Mr.1749
SequenceYELLHGAGNHAAGILTL-NH2
Labeling TargetOrexin OX1 receptor
AppearanceWhite lyophilised solid
Purity>97%
ActivityAntagonist
Areas of InterestObesity Research
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 The serine/threonine kinase Pim-1 plays an important role in cell cycle progression and apoptosis inhibition, re ...

  Etomidate, a highly selective intravenous anesthetic agent, was first synthesized at Janssen Pharmaceuticals in ...

 Jingzhaotoxin-III (β-TRTX-Cj1α) is a kind of sodium channel gating modifier which is from the tarantula Chilobra ...

 Ziconotide (previously called SNX-111), currently marketed under the brand name of Prialt, is the synthetic form ...

 Sincalide is a brain and intestinal skin with a variety of physiological effects. It is widely distributed in th ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.